Fonseca, Rafael http://orcid.org/0000-0002-5938-3769
Hagiwara, May http://orcid.org/0000-0002-5796-2580
Panjabi, Sumeet
Yucel, Emre
Buchanan, Jacqueline
Delea, Thomas
Article History
Received: 20 October 2020
Revised: 4 January 2021
Accepted: 25 January 2021
First Online: 16 February 2021
Conflict of interest
: J.B. is currently an employee of Amgen, Inc. and S.P. and E.Y. were employees of Amgen, Inc. and all hold Amgen Stock. R.F. is a consultant for Amgen, BMS, Celgene, Takeda, Bayer, Janssen, Novartis, Pharmacyclics, Sanofi, Merck, Juno, Kite, Aduro, OncoTracker, Oncopeptides, GSK, and AbbVie, and is on the Scientific Advisory Board of Adaptive Biotechnologies and OncoTracker. M.H. and T.E.D. received research funding from Amgen, Celgene, EMD Serono, Jazz, Merck, Novartis, Pfizer, Sanofi, Seattle Genetics, and Takeda.